BTK covalent and reversible inhibitor therapy(Eilean Therapeutics)
N/A
Report date: 2024/10/10 11:20:25
NME
Base Information
Drug NameBTK covalent and reversible inhibitor therapy(Eilean Therapeutics)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEilean Therapeutics LLC
China Registration ClassN/A
Develop Information
Active CompaniesEilean Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A